XML 17 R7.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities    
Net (loss) income $ (88,587) $ (23)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 13,849 12,733
Stock-based compensation 6,568 7,108
Amortization of premium on marketable securities 315 634
Undistributed (earnings) losses of equity method investments (869) 605
Deferred income tax provision (benefit) 73,454 (2,728)
Gain on disposal of long-lived assets 0 (4)
Changes in operating assets and liabilities, net of acquisitions and disposals:    
Accounts receivable (664) (13,269)
Inventories (374) 2,474
Prepaid expenses and other current assets (2,046) (5,365)
Accounts payable (7,073) 8,345
Deferred revenue 15,538 (3,868)
Accrued warranty and retrofit costs (333) (274)
Accrued compensation and benefits (7,297) (6,200)
Accrued restructuring costs 5,323 (6)
Accrued expenses and other current liabilities (7,433) 4,791
Net cash provided by operating activities 371 4,953
Cash flows from investing activities    
Purchases of property, plant and equipment (6,090) (3,647)
Purchases of marketable securities (12,900) (30,739)
Sales and maturities of marketable securities 139,388 47,625
Disbursement for a loan receivable 741 0
Acquisitions, net of cash acquired (125,498) (17,257)
Proceeds from sales of property, plant and equipment 0 6
Purchases of other investments (250) (5,000)
Net cash used in investing activities (6,091) (9,012)
Cash flows from financing activities    
Proceeds from issuance of common stock 948 867
Principal repayments of capital lease obligations 0 (244)
Common stock dividends paid (13,738) (13,480)
Net cash used in financing activities (12,790) (12,857)
Effects of exchange rate changes on cash and cash equivalents (50) (4,022)
Net decrease in cash and cash equivalents (18,560) (20,938)
Cash and cash equivalents, beginning of period 80,722 94,114
Cash and cash equivalents, end of period $ 62,162 $ 73,176